Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer's disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea.

While this change from baseline did not reach statistical significance, it is in line with the results of previous studies in more homogeneous patient groups ( Katona et al., 2012 ; McIntyre et al., 2014 ; Mahableshwarkar et al., 2015 ; Mattingly et al., 2022 ).

also in 111,027 other papers